SEQUANA MEDICAL NV (SEQUA.BR) Stock Overview
EBR:SEQUA - BE0974340722 - Common Stock
SEQUA.BR Key Statistics, Chart & Performance
The current stock price of SEQUA.BR is 1.062 EUR. In the past month the price decreased by -13.68%. In the past year, price increased by 14.47%.
SEQUA.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.04 | 198.13B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 57.19 | 141.67B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 37.61 | 135.43B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 37.12 | 133.45B | ||
| 2M6.DE | MEDTRONIC PLC | 16.72 | 101.90B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.87 | 53.35B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.85 | 53.29B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.29 | 46.68B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 31.57 | 40.97B | ||
| DC4.DE | DEXCOM INC | 43.73 | 25.04B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.53 | 22.93B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.53 | 22.92B |
Related stock screener links
About SEQUA.BR
Company Profile
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
Company Info
SEQUANA MEDICAL NV
Kortrijksesteenweg 1112, Sint-Denijs-Westrem
Ghent OOST-VLAANDEREN BE
Employees: 48
Phone: 3292928065.0
SEQUANA MEDICAL NV / SEQUA.BR FAQ
What is the stock price of SEQUANA MEDICAL NV today?
The current stock price of SEQUA.BR is 1.062 EUR. The price increased by 0.95% in the last trading session.
What is the ticker symbol for SEQUANA MEDICAL NV stock?
The exchange symbol of SEQUANA MEDICAL NV is SEQUA and it is listed on the Euronext Brussels exchange.
On which exchange is SEQUA.BR stock listed?
SEQUA.BR stock is listed on the Euronext Brussels exchange.
What is the price forecast or stock price prediction for SEQUANA MEDICAL NV stock?
9 analysts have analysed SEQUA.BR and the average price target is 3.57 EUR. This implies a price increase of 236.16% is expected in the next year compared to the current price of 1.062. Check the SEQUANA MEDICAL NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SEQUANA MEDICAL NV worth?
SEQUANA MEDICAL NV (SEQUA.BR) has a market capitalization of 62.16M EUR. This makes SEQUA.BR a Micro Cap stock.
How many employees does SEQUANA MEDICAL NV have?
SEQUANA MEDICAL NV (SEQUA.BR) currently has 48 employees.
What are the support and resistance levels for SEQUANA MEDICAL NV (SEQUA.BR) stock?
SEQUANA MEDICAL NV (SEQUA.BR) has a support level at 1 and a resistance level at 1.07. Check the full technical report for a detailed analysis of SEQUA.BR support and resistance levels.
Is SEQUANA MEDICAL NV (SEQUA.BR) expected to grow?
The Revenue of SEQUANA MEDICAL NV (SEQUA.BR) is expected to grow by 733.33% in the next year. Check the estimates tab for more information on the SEQUA.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SEQUANA MEDICAL NV (SEQUA.BR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SEQUA.BR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SEQUA.BR, evaluating the profitability, health, valuation and growth aspects
- SEQUANA MEDICAL NV (SEQUA.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SEQUANA MEDICAL NV (SEQUA.BR) Sales and EPS estimates to see what analysts future expectations are.
- SEQUANA MEDICAL NV (SEQUA.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SEQUANA MEDICAL NV (SEQUA.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
- SEQUANA MEDICAL NV (SEQUA.BR) Stock Chart to make your own analysis
- SEQUANA MEDICAL NV (SEQUA.BR) Latest news and press-releases to stay up to date.
Does SEQUANA MEDICAL NV (SEQUA.BR) stock pay dividends?
SEQUA.BR does not pay a dividend.
When does SEQUANA MEDICAL NV (SEQUA.BR) report earnings?
SEQUANA MEDICAL NV (SEQUA.BR) will report earnings on 2025-09-04.
What is the Price/Earnings (PE) ratio of SEQUANA MEDICAL NV (SEQUA.BR)?
SEQUANA MEDICAL NV (SEQUA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.2).
SEQUA.BR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SEQUA.BR. When comparing the yearly performance of all stocks, SEQUA.BR is one of the better performing stocks in the market, outperforming 79.18% of all stocks.
SEQUA.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR. Both the profitability and financial health of SEQUA.BR have multiple concerns.
SEQUA.BR Financial Highlights
Over the last trailing twelve months SEQUA.BR reported a non-GAAP Earnings per Share(EPS) of -1.2. The EPS increased by 1.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -449.06% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SEQUA.BR Forecast & Estimates
9 analysts have analysed SEQUA.BR and the average price target is 3.57 EUR. This implies a price increase of 236.16% is expected in the next year compared to the current price of 1.062.
For the next year, analysts expect an EPS growth of 38.1% and a revenue growth 733.33% for SEQUA.BR